A novel loss-of-function mutation in TTF-2 is associated with congenital hypothyroidism, thyroid agenesis and cleft palate

被引:108
作者
Castanet, M
Park, SM
Smith, A
Bost, M
Léger, J
Lyonnet, S
Pelet, A
Czernichow, P
Chatterjee, K
Polak, M
机构
[1] Paediat Endocrinol Unit, Paris, France
[2] INSERM, U457, Paris, France
[3] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
[4] CHU Grenoble, Dept Pediat, Paris, France
[5] INSERM, U393, Paris, France
基金
英国惠康基金;
关键词
D O I
10.1093/hmg/11.17.2051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thyroid dysgenesis is the most common cause of congenital hypothyroidism (CH) and its genetic basis is largely unknown. Here, we describe the second homozygous missense mutation in TTF-2 (or FOXE1), a transcription factor that has been implicated in thyroid development. Two male siblings, born to consanguineous parents, presented with CH, athyreosis and cleft palate and were found to be homozygous for a mutation corresponding to a serine to asparagine substitution at codon 57 (S57N) in the forkhead DNA binding domain of TTF-2. Their heterozygous parents were unaffected and this mutation was not found in 31 unrelated cases of athyreosis or normal controls. Consistent with its location, the S57N TTF-2 mutant protein showed impaired DNA binding and partial loss of transcriptional function. Such incomplete loss of TTF-2 function may account for the absence of choanal atresia and bifid epiglottis in our patients, anomalies which were present together with CH and cleft palate in two other individuals with the only other, more deleterious, TTF-2 mutation (A65V) described previously. Our observations support the role of TTF-2 in both thyroid and palate development but suggest phenotypic heterogeneity of this syndromic form of CH.
引用
收藏
页码:2051 / 2059
页数:9
相关论文
共 29 条
[11]   2ND INTERNATIONAL-CONFERENCE ON NEONATAL THYROID SCREENING - PROGRESS REPORT [J].
FISHER, DA .
JOURNAL OF PEDIATRICS, 1983, 102 (05) :653-654
[12]   CELL-TYPE-SPECIFIC EXPRESSION OF THE RAT THYROPEROXIDASE PROMOTER INDICATES COMMON MECHANISMS FOR THYROID-SPECIFIC GENE-EXPRESSION [J].
FRANCISLANG, H ;
PRICE, M ;
POLYCARPOUSCHWARZ, M ;
DILAURO, R .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (02) :576-588
[13]   SURVEY OF NEONATAL SCREENING FOR PRIMARY HYPOTHYROIDISM IN ENGLAND, WALES, AND NORTHERN-IRELAND 1982-4 [J].
GRANT, DB ;
SMITH, I .
BRITISH MEDICAL JOURNAL, 1988, 296 (6633) :1355-1358
[14]   Polymorphism of the polyalanine tract of thyroid transcription factor-2 gene in patients with thyroid dysgenesis [J].
Hishinuma, A ;
Ohyama, Y ;
Kuribayashi, T ;
Nagakubo, N ;
Namatame, T ;
Shibayama, K ;
Arisaka, O ;
Matsuura, N ;
Ieiri, T .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (04) :385-389
[15]  
KAPLAN EL, 1994, ENDOCRINOLOGY, P893
[16]   The T/ebp null mouse thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary [J].
Kimura, S ;
Hara, Y ;
Pineau, T ;
FernandezSalguero, P ;
Fox, CH ;
Ward, JM ;
Gonzalez, FJ .
GENES & DEVELOPMENT, 1996, 10 (01) :60-69
[17]   HNF-3A, A HEPATOCYTE-ENRICHED TRANSCRIPTION FACTOR OF NOVEL STRUCTURE IS REGULATED TRANSCRIPTIONALLY [J].
LAI, E ;
PREZIOSO, VR ;
SMITH, E ;
LITVIN, O ;
COSTA, RH ;
DARNELL, JE .
GENES & DEVELOPMENT, 1990, 4 (08) :1427-1436
[18]  
LAPI P, 2000, C END SOC, P761
[19]   Congenital hypothyroidism in Wales (1982-1993): demographic features, clinical presentation and effects on early neurodevelopment [J].
Law, WY ;
Bradley, DM ;
Lazarus, JH ;
John, R ;
Gregory, JW .
CLINICAL ENDOCRINOLOGY, 1998, 48 (02) :201-207
[20]   Molecular genetics of congenital hypothyroidism [J].
Macchia, PE ;
De Felice, M ;
Di Lauro, R .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (03) :289-294